Measles Vaccine Patch Could Simplify Immunizations in Minnesota, Boost Rural Access

Why it matters locally: The development of a measles microneedle patch has several potential implications for Minnesota residents, particularly those in rural areas. Minnesota has a significant population distributed across less densely populated regions, and access to healthcare, including vaccinations, can be a barrier for some. This patch, if successful, could simplify vaccine administration, potentially allowing for wider distribution through pharmacies or even at-home application after a consultation, reducing the need for frequent trips to clinics and thus improving vaccination rates in these underserved areas.

---

Atlanta, GA – A collaborative effort between the Georgia Institute of Technology and the Centers for Disease Control and Prevention (CDC) is focused on creating a microneedle patch designed to deliver measles vaccines. The research team hopes the new technology will offer several advantages over traditional injection methods. The patch utilizes microscopic needles, imperceptible to the naked eye, to administer the vaccine under the skin. This method could potentially eliminate the need for trained medical personnel to administer the shots. The developers hope the patch format will make measles vaccination more accessible in locations with limited resources. While details on the patch's composition and clinical trial timelines remain undisclosed, the project signifies ongoing efforts to improve vaccine delivery systems and combat vaccine-preventable diseases like measles. The project aims to create a more stable, easy-to-administer alternative to traditionally refrigerated and injected vaccines. If successful at scale, this could offer wider access to vaccination which could reduce cases and potential spread of the disease.